ArticlemSphere2018

Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.

Sara Mercader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.